142 related articles for article (PubMed ID: 11154803)
1. Myasthenia gravis on the Dutch antilles: an epidemiological study.
Holtsema H; Mourik J; Rico RE; Falconi JR; Kuks JB; Oosterhuis HJ
Clin Neurol Neurosurg; 2000 Dec; 102(4):195-198. PubMed ID: 11154803
[TBL] [Abstract][Full Text] [Related]
2. A population based epidemiological study on myasthenia gravis in Estonia.
Oöpik M; Kaasik AE; Jakobsen J
J Neurol Neurosurg Psychiatry; 2003 Dec; 74(12):1638-43. PubMed ID: 14638881
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of seropositive myasthenia gravis in Greece.
Poulas K; Tsibri E; Kokla A; Papanastasiou D; Tsouloufis T; Marinou M; Tsantili P; Papapetropoulos T; Tzartos SJ
J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):352-6. PubMed ID: 11511710
[TBL] [Abstract][Full Text] [Related]
4. A national epidemiological study of Myasthenia Gravis in Australia.
Gattellari M; Goumas C; Worthington JM
Eur J Neurol; 2012 Nov; 19(11):1413-20. PubMed ID: 22469211
[TBL] [Abstract][Full Text] [Related]
5. A nationwide epidemiological study of myasthenia gravis in Latvia.
Zieda A; Ravina K; Glazere I; Pelcere L; Naudina MS; Liepina L; Kamsa I; Kurjane N; Woodhall M; Jacobson L; Leite MI; Tandon K; Kenina V
Eur J Neurol; 2018 Mar; 25(3):519-526. PubMed ID: 29194859
[TBL] [Abstract][Full Text] [Related]
6. Incidence and prevalence of myasthenia gravis in western Denmark: 1975 to 1989.
Christensen PB; Jensen TS; Tsiropoulos I; Sørensen T; Kjaer M; Højer-Pedersen E; Rasmussen MJ; Lehfeldt E; de Fine Olivarius B
Neurology; 1993 Sep; 43(9):1779-83. PubMed ID: 8414031
[TBL] [Abstract][Full Text] [Related]
7. [Some epidemiological aspects of myasthenia gravis in Cuba].
Cisneros AD; Luis RS; León R; Carrera PL
Rev Neurol; 1996 Apr; 24(128):435-9. PubMed ID: 8721922
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in The Netherlands.
Niks EH; Kuks JB; Verschuuren JJ
J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):417-8. PubMed ID: 17056627
[TBL] [Abstract][Full Text] [Related]
9. Incidence of myasthenia gravis in the province of Ferrara: a community-based study.
Casetta I; Fallica E; Govoni V; Azzini C; Tola M; Granieri E
Neuroepidemiology; 2004; 23(6):281-4. PubMed ID: 15297794
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of myasthenia gravis in Northern Portugal: Frequency estimates and clinical epidemiological distribution of cases.
Santos E; Coutinho E; Moreira I; Silva AM; Lopes D; Costa H; Silveira F; Nadais G; Morais H; Martins J; Branco MC; Veiga A; Silva RS; Ferreira A; Sousa F; Freijo M; Matos I; André R; Negrão L; Fraga C; Santos M; Sampaio M; Lopes C; Leite MI; Gonçalves G
Muscle Nerve; 2016 Sep; 54(3):413-21. PubMed ID: 26851892
[TBL] [Abstract][Full Text] [Related]
11. Incidence and prevalence of myasthenia gravis in the county of the coast and Gorski kotar, Croatia, 1976 through 1996.
Zivadinov R; Jurjevic A; Willheim K; Cazzato G; Zorzon M
Neuroepidemiology; 1998; 17(5):265-72. PubMed ID: 9705586
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological and clinical characteristics of myasthenia gravis in Belgrade, Yugoslavia (1983-1992).
Lavrnić D; Jarebinski M; Rakocević-Stojanović V; Stević Z; Lavrnić S; Pavlović S; Trikić R; Tripković I; Nesković V; Apostolski S
Acta Neurol Scand; 1999 Sep; 100(3):168-74. PubMed ID: 10478580
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological and immunological profile of muscle-specific kinase myasthenia gravis in Greece.
Tsiamalos P; Kordas G; Kokla A; Poulas K; Tzartos SJ
Eur J Neurol; 2009 Aug; 16(8):925-30. PubMed ID: 19374661
[TBL] [Abstract][Full Text] [Related]
14. Juvenile myasthenia gravis in Norway: A nationwide epidemiological study.
Popperud TH; Boldingh MI; Brunborg C; Faiz KW; Heldal AT; Maniaol AH; Müller KI; Rasmussen M; Øymar K; Kerty E
Eur J Paediatr Neurol; 2017 Mar; 21(2):312-317. PubMed ID: 27666466
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of myasthenia gravis in Ontario, Canada.
Breiner A; Widdifield J; Katzberg HD; Barnett C; Bril V; Tu K
Neuromuscul Disord; 2016 Jan; 26(1):41-6. PubMed ID: 26573434
[TBL] [Abstract][Full Text] [Related]
16. Incidence and characteristics of Myasthenia gravis in Dar Es Salaam, Tanzania.
Matuja WB; Aris EA; Gabone J; Mgaya EM
East Afr Med J; 2001 Sep; 78(9):473-6. PubMed ID: 11921580
[TBL] [Abstract][Full Text] [Related]
17. The Epidemiology of Myasthenia Gravis in Korea.
Lee HS; Lee HS; Shin HY; Choi YC; Kim SM
Yonsei Med J; 2016 Mar; 57(2):419-25. PubMed ID: 26847295
[TBL] [Abstract][Full Text] [Related]
18. Myasthenia gravis and elderly people.
Schon F; Drayson M; Thompson RA
Age Ageing; 1996 Jan; 25(1):56-8. PubMed ID: 8670530
[TBL] [Abstract][Full Text] [Related]
19. Geographical distribution of a seropositive myasthenia gravis population.
Heldal AT; Eide GE; Gilhus NE; Romi F
Muscle Nerve; 2012 Jun; 45(6):815-9. PubMed ID: 22581533
[TBL] [Abstract][Full Text] [Related]
20. Seropositive myasthenia gravis: a nationwide epidemiologic study.
Heldal AT; Owe JF; Gilhus NE; Romi F
Neurology; 2009 Jul; 73(2):150-1. PubMed ID: 19597135
[No Abstract] [Full Text] [Related]
[Next] [New Search]
